This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dcthttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n10https://global.dbpedia.org/id/
n13http://en.wikipedia.org/wiki/Amlodipine/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n15http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n17https://druginfo.nlm.nih.gov/drugportal/name/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n2http://dbpedia.org/resource/Amlodipine/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
n2:celecoxib
rdf:type
owl:Thing dbo:CombinationDrug dbo:Drug wikidata:Q8386 n15:ChemicalObject dbo:ChemicalSubstance
rdfs:label
Amlodipine/celecoxib
rdfs:comment
Amlodipine/celecoxib, sold under the brand name Consensi, is a fixed-dose combination medication used to treat both hypertension and osteoarthritis at the same time in adults. It contains amlodipine besylate and celecoxib. It is taken by mouth. The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash. It was approved for medical use in the United States in May 2018.
dct:subject
dbc:Combination_drugs
dbo:wikiPageID
63952079
dbo:wikiPageRevisionID
1079516507
dbo:wikiPageWikiLink
dbr:Oral_administration dbr:Amlodipine_besylate dbr:Celecoxib dbr:Fixed-dose_combination dbc:Combination_drugs dbr:Nonsteroidal_anti-inflammatory_drug dbr:Osteoarthritis dbr:Hypertension dbr:Calcium_channel_blocker
dbo:wikiPageExternalLink
n17:amlodipine%20%252F%20celecoxib
owl:sameAs
n10:BxB9n wikidata:Q96371968
dbp:wikiPageUsesTemplate
dbt:Cite_web dbt:Portal_bar dbt:Cardiovascular-drug-stub dbt:Use_American_English dbt:Reflist dbt:Infobox_drug dbt:Use_dmy_dates dbt:Short_description dbt:Ion_channel_modulators dbt:Drugs.com
dbp:atcSuffix
CA51
dbp:atcPrefix
8.0
dbp:class
dbr:Nonsteroidal_anti-inflammatory_drug dbr:Calcium_channel_blocker
dbp:component
Amlodipine Celecoxib
dbp:kegg
D11705
dbp:legalUs
Rx-only
dbp:routesOfAdministration
dbr:Oral_administration
dbp:tradename
Consensi
dbp:type
combo
dbo:abstract
Amlodipine/celecoxib, sold under the brand name Consensi, is a fixed-dose combination medication used to treat both hypertension and osteoarthritis at the same time in adults. It contains amlodipine besylate and celecoxib. It is taken by mouth. The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash. It was approved for medical use in the United States in May 2018.
dbp:dailymedid
Amlodipine_besylate_and_celecoxib
prov:wasDerivedFrom
n13:celecoxib?oldid=1079516507&ns=0
dbo:wikiPageLength
4834
dbo:alternativeName
Consensi
dbo:kegg
D11705
foaf:isPrimaryTopicOf
n13:celecoxib